CRP and cancer: Consistent with a previous meta-analysis of frailty biomarkers in primarily non-cancer diagnoses of older adults (18), CRP and fibrinogen emerged as correlates of phenotypic and deficit accumulation frailty at pre-treatment (31) and with phenotypic frailty during treatment (36).